Distal Extremity Necrosis as a Manifestation of Cutaneous Polyarteritis Nodosa: Case Report and Review of the Acute Management of a Pediatric Patient

2012 ◽  
Vol 29 (4) ◽  
pp. 473-478 ◽  
Author(s):  
Victoria L. Williams ◽  
Ricardo Guirola ◽  
Kristy Flemming ◽  
Gunjan M. Modi ◽  
Cecilia Rosales ◽  
...  
2005 ◽  
Vol 53 (3) ◽  
pp. 468-470 ◽  
Author(s):  
Brent Culver ◽  
Aleksandr Itkin ◽  
Ken Pischel

2018 ◽  
Vol 54 (1) ◽  
pp. 112-115
Author(s):  
Lauren M. L'Hommedieu ◽  
Michael W. Dingeldein ◽  
Krystal L. Tomei ◽  
Brendan J. Kilbane

2018 ◽  
Vol 2 (5) ◽  
Author(s):  
Lubna Nazir

Polyarteritis nodosa is a rare form of systemic vasculitis. Cutaneous polyarteritis nodosa (cPAN) is subtype of systemic PAN which predominantly affects the skin, extra-cutaneous findings include fever, malaise, myalgias, arthralgias, and neuropathy. The true incidence of cutaneous PAN is unknown. cPAN is recognized as a separate entity and is essentially a benign disorder which should be distinguished from systemic PAN, as the clinical course and management of the two conditions is different. In this case report, we have described a patient with fever and gangrene of both hands and feet. The patient underwent a very extensive workup in order to determine the cause of her condition, which finally turned out cPAN on skin biopsy


2020 ◽  
Vol 4 (2) ◽  
pp. 272-277
Author(s):  
Takahiro Iwata ◽  
Hiromu Ito ◽  
Moritoshi Furu ◽  
Masahiro Ishikawa ◽  
Masayuki Azukizawa ◽  
...  

2018 ◽  
Vol 22 (5) ◽  
pp. 516-518 ◽  
Author(s):  
Derek To ◽  
Scott Bradshaw ◽  
Jennifer Lipson

Polyarteritis nodosa (PAN) is a rare vasculitis affecting medium-sized vessels. Cutaneous PAN is a clinical variant, and we report the first case of empagliflozin-induced cutaneous PAN in a 69-year-old man. After starting empagliflozin, the patient presented with tender subcutaneous nodules on his legs, which showed a medium-sized vessel vasculitis on histopathology. Upon cessation of this medication, he had full resolution of these nodules. This case illustrates that empagliflozin can induce cutaneous PAN, and further attention to this medication’s association with cutaneous PAN is warranted.


2021 ◽  
Author(s):  
Reinan Tavares Campos ◽  
Lucia Maria Mattei Arruda Campos ◽  
Clovis Arthur A Silva ◽  
Pedro Vale Bede ◽  
Maria Fernanda Badue Pereira ◽  
...  

2020 ◽  
Vol 8 ◽  
pp. 2050313X2095311
Author(s):  
Roxana Mititelu ◽  
Larry W Cheung ◽  
Denis Sasseville

We report a unique case of a patient presenting with histologically confirmed pseudoxanthoma elasticum–like phenotype and cutaneous polyarteritis nodosa. Cardiac, gastroenterological, and ophthalmologic evaluations were within normal limits. Genetic evaluation was pertinent for absent ABCC6, ENPP1, and GGCX mutations and a normal array comparative genomic hybridization. Extensive workup revealed skin-limited cutaneous polyarteritis nodosa, and further genetic testing for ADA2 deficiency was negative. The cutaneous polyarteritis nodosa lesions had an excellent response to hydroxychloroquine and methotrexate. Pseudoxanthoma elasticum and polyarteritis nodosa are relatively uncommon, and our patient is among the first reported cases presenting with both pseudoxanthoma elasticum–like and polyarteritis nodosa. Furthermore, this case emphasizes the importance of a thorough cutaneous exam, as the patient had the lesions consistent with pseudoxanthoma elasticum–like since childhood and had previously gone undiagnosed.


2016 ◽  
Vol 28 (6) ◽  
pp. 1049-1052 ◽  
Author(s):  
Toshitaka Kizawa ◽  
Yuko Yoto ◽  
Miyako Mizukami ◽  
Takeshi Tsugawa ◽  
Takako Takeuchi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document